当前位置： SCI文献检索 > PHARMACOTHERAPY期刊下所有文献 > Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.

Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.

Abstract：

:Abstract Outbreaks of extensively drug-resistant tuberculosis (XDR-TB) in developing countries and recent headlines of an American traveling with a resistant variant of tuberculosis have brought XDR-TB into the spotlight. The World Health Organization and the United States Centers for Disease Control and Prevention have identified XDR-TB as a serious public health threat and are mandating increased efforts at control of tuberculosis. Although XDR-TB is believed to be no more infectious than other variants of tuberculosis, infection with and spread of XDR-TB are concerning because of the ineffectiveness, toxicity, and cost of the available tuberculosis treatment options. Pharmacists may not be aware of the recent trends in tuberculosis resistance or of the impact that they can have on educating the public about this disease. To gain a better understanding of this disease and the potential roles for pharmacists in public health awareness of tuberculosis and in the care of patients with and at risk for this disease, we undertook an extensive search of the Internet, including Web sites of tuberculosis advocacy groups, and of MEDLINE from January 1968-March 2008. Currently, XDR-TB infection is uncommon in the United States, but if history is any indication, there is a high potential for an outbreak or epidemic. The XDR-TB variant has emerged from mismanaging multidrug-resistant tuberculosis, treating tuberculosis with too few drugs, using less effective second-line drugs, and not educating patients about the dangers of nonadherence. With only limited hopes of a novel effective drug combination regimen, use of available antimycobacterial drugs needs to be optimized. Pharmacists can be key players in the prevention and treatment of tuberculosis by promoting adherence, assessing patients for risk factors for resistant disease, providing information about disease control and prevention, and monitoring for effectiveness, adverse effects, and drug interactions.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Mitrzyk BM

doi

10.1592/phco.28.10.1243

subject

Has Abstract

pub_date

2008-10-01 00:00:00

pages

1243-54

issue

eissn

0277-0008

issn

1875-9114

pii

10.1592/phco.28.10.1243

journal_volume

pub_type

杂志文章,评审

在线工具

Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.